Introduction
In acute coronary syndrome (ACS), an invasive strategy improves survival, rates of myocardial infarction, stroke, and the need of urgent revascularisation compared with a conservative approach [1] [2] [3] . Thus, the current guidelines from the American Heart Association, American College of Cardiology, and the European Society of Cardiology, all recommend medical stabilisation leading to an evaluation for invasive intervention [4, 5] . However, the evidence for this recommendation has, until recently, only been demonstrated for younger patients [6] . In large randomised controlled trials investigating the effects of revascularisation versus medical therapy, patients aged 80 years or more are under-represented. This bias largely prevents any sub-analyses of the benefits of different management strategies for this patient subset. According to registry data, older patients with ACS are also less likely to see a cardiologist and a conservative strategy is often preferred by generalists due to co-morbidity [7] .
In the After Eighty Study, patients aged 80 years or over, with non-ST-elevation myocardial infarction (NSTEMI), and unstable angina pectoris (UAP), were randomised to either an invasive or conservative strategy [8] . The primary endpoint was a composite of myocardial infarction, need for urgent revascularisation, stroke or death. The results demonstrated that an invasive strategy was superior to a conservative one and that bleeding complication rates did not differ between the two. During a median follow-up of 1.53 years, the incidence of the primary endpoint occurred in 40.6% in the invasive group and 61.4% in the conservative group (adjusted hazard ratio: 0.51; 95% confidence intervals (CI): 0.39-0.67, P = 0.0001). Hazard ratios for the four components of the primary composite endpoint were 0.51 (95% CI: 0.34-0.75, P = 0.001) for myocardial infarction, 0.19 (95% CI: 0.07-0.52, P = 0.001) for the need for urgent revascularisation, 0.62 (95% CI: 0.26-1.51, P = 0.295) for stroke, and 0.87 (95% CI: 0.61-1.26, P = 0.483) for death from any cause. A dilution of efficacy of the invasive strategy was, however, observed with increasing age which also is in accordance with registry data [9] . Consequently, decision making in older people must be individually tailored and taking into account life-expectancy, comorbid illnesses, risks of bleeding, cognitive, and functional status, and patient preference [8, 10] . The effects of an invasive management on health related quality of life (HRQOL) are presently unknown for this age group.. In the present study we sought to compare the effects of these management strategies on HRQOL changes after 1 year.
Methods
The After Eighty study (ClinicalTrials.gov.number NCT012 55540) was an open-label, prospective, randomised, controlled, multicenter trial, as described previously [8] . Between December 2010 and February 2014, 457 patients of 80 years of age or over, with NSTEMI or UAP, and admitted to 16 hospitals without PCI facilities in the South-East Health Region of Norway, were recruited. Patients were evaluated for participating in the study within 2 days of their hospital admission, on a daily, year-round basis. After providing written informed consent, patients were randomised to one of two strategies: an invasive strategy involving early coronary angiography with immediate evaluation for ad hoc percutaneous coronary intervention (PCI), coronary artery bypass graft (CABG) or optimal medical therapy (OMT), or to a conservative strategy, i.e. OMT.
The Short Form 36 health survey (SF-36) was used to assess HRQOL. SF-36 consists of 36 items that measure eight domains of health; physical functioning (PF), role limitations due to physical problems (RP), bodily pain (BP), general health perception (GH), vitality (VT), social functioning (SF), role limitations due to emotional problems (RE) and mental health (MH). Responses to each item within a dimension are combined to generate an overall score of 0-100, where 100 indicates the best possible health [11] . SF-36 has shown satisfactory reliability and has been validated in several countries, including Norway [12] . The psychometric properties of the SF-36 have been tested and found to be suitable for evaluating HRQOL in cardiac surgery patients [13] . The HRQOL SF-36 forms were collected in both groups at baseline (at the day of inclusion) and at the 1-year follow-up. Both groups were observed and medically treated according to existing guidelines [4, 14, 15] . After 12 months, the patients received the follow-up SF-36 form together with an explanatory letter. Patients who did not respond received reminders by phone and correspondence.
Statistical analysis
The endpoint was the difference between follow-up and baseline (i.e. delta). Differences in HRQOL changes were analysed using the Mann-Whitney test at follow-up and baseline. 95% CI is reported with two-sided P-values < 0.05 considered to be statistically significant. A-priori power analysis was not performed because we do not know what a clinically significant meaningful difference between intervention and non-intervention is in the SF-36 components. If we postulate that a change in 10% is clinically significant meaningful between the two arms for a type I error of 5% and a power of 80%, the sample size in the present sub-study is satisfactory. On the other hand, if we consider 5% to be clinically significant meaningful for a type I error of 5% and a power of 80%, the sample size in the present sub-study is satisfactory, except for the change (delta) in the components 'role physical' and 'role emotional' where we have a defacto power of 74 and 62%, respectively, for a type I error of 5%.
Reliability and validity analysis for the SF-36 questionnaire were carried out using the Cronbach alpha method [16] . For the clinical application of the SF-36, the minimum Cronbach α must be 0.90; for comparing groups, α values of 0.7-0.8 are regarded as satisfactory.
Results
During the inclusion period, 229 patients (mean age: 84.7 years) in the invasive group, and 228 patients (mean age: 84.9 years) in the conservative group were randomised. In total, 208 patients in the invasive group, and 216 patients in the conservative group, completed the SF-36 questionnaire at baseline. Within 24 h of randomisation, two dropouts occurred in the invasive group, and one in the conservative group. Overall, 49 patients in the invasive group and 48 in the conservative group died before follow-up. Three patients in the invasive group and four patients in the conservative Health related quality of life in older patients group developed dementia. One patient in each group was unable to read due to problems with their vision, and one patient in the invasive group had, according to relatives, serious psychological problems that prevented their completion of the follow-up SF-36. We lost contact with 15 patients in each despite written and phone reminders (Figure 1) . Finally, 137 patients in the invasive group and 136 patients in the conservative group completed the follow-up SF-36 questionnaire in each strategy arm. See Table 1 for baseline characteristics of the two study arms.
Health related quality of life
From baseline to follow-up no significant changes in quality-of-life scores were observed in any of the subscales in the invasive or conservative group (Table 2) . When comparing the changes from follow-up to baseline (delta) no significant changes in quality-of-life scores were observed between the two strategies in any of the domains, expect for a small but statistically significant difference in bodily pain (P = 0.0267) ( Table 3 ). The internal consistencies for all SF-36 domains were found to be satisfactory for comparisons to be made.
Cronbach alpha estimates showed a good internal consistency of our questionnaire. Due to a lack of normative HRQOL data for the Norwegian population aged 80 years or more, it was impossible to perform a comparison with the general population.
Discussion
The After Eighty study randomised patients with NSTEMI or UAP, aged 80 years or older, to either an invasive or conservative treatment strategy [8] . The invasive strategy reduced the composite of myocardial infarction, need for urgent revascularisation, stroke and death without increasing bleeding complications, compared to the conservative strategy. Expect for a small but statistically significant difference 
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in bodily pain, these results do not, however, translate into convincing clinical changes in HRQOL, as measured by the SF-36. One may expect a beneficial effect on the SF-36 variables in a trial like this, given the reduction in new myocardial infarctions and reinterventions in the invasive group. However, as we are in a longitudinal design, the study is biased by non-random dropouts in both arms and we have to be careful in the interpretation of the results. The nondifferences in HRQOL changes between the two arms, however, will not exclude the superiority of an invasive strategy over a conservative strategy, when factoring major cardiovascular event outcomes. Improving prognosis, symptoms and QOL are the main reasons for treating patients. Measurements of prognostic factors and easily defined hard endpoints such as repeat revascularisation, repeat hospitalisation, reinfarction, stroke and death are easier than measuring a complex entity like HRQOL which is influenced by multiple factors (e.g. personality, culture, age, sex, religion, expectations, coping). SF-36 has a main focus on general health perspectives and has not been fully validated in older people. Thus, SF-36 may therefore not be the most sensitive and reliable tool for measuring heart related HRQOL in older people with ACSs. On the other hand, more disease specific questionnaires, such as the Seattle Angina questionnaire (SAQ) for angina pectoris, Kansas city or Minnesota questionnaire for heart failure or the Duke Activity Status Index, has not been validated in these very old patients as well. Important is that older patients with ACS present a rather heterogeneous group due to their frailty, age-based differences in physiologic aging, comorbidities, functional status, and social aspects [10] . Furthermore, older patient's condition is often complicated by poor memory. When returning the follow-up SF-36 questionnaire, many of the patients used the opportunity to add additional/supplementary information in separate letters, or by writing informative text directly on the questionnaire, with the message that their daily problems were not related to their heart disease. Taking these responses into account SAQ or the Duke Activity Status Index, might have been a more appropriate tool [17] . Table 1 . Baseline characteristics. Values are mean ± SD or (%). There were no significant differences between the two study groups in any characteristic at baseline except for previous CABG (P = 0.008). 
Health related quality of life in older patients
One may also suggest that a personal interview is superior to a written questionnaire, but this may increase the risk of bias due to the patient-doctor relationship. Thus, many competing factors contribute to the experienced health quality. These factors will dilute the appropriateness of any measurement tool trying to measure the effect of a specific intervention. Overall, data from registries and non-randomised trials suggest an improved HRQOL in octogenarians following PCI [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] . Older patients improve at least as much as younger, and may even benefit more in the areas of physical function, and improved angina status. The benefits are greatest in the first 6 months, continuing for at least 3 years. There is also some evidence to show functional improvement and an enhanced quality of life after coronary intervention in nonagenarians [28] . In a previous trial of octogenarians with chronic symptomatic coronary artery disease randomised to invasive or medical therapy, no differences were seen in HRQOL [29] , which is in accordance with the findings of the present trial.
Comparing the results of the present study with those of previous trials is not a straightforward proposition. For a start, there are no other studies of HRQOL in patients aged 80 years or more, from randomised controlled multicenter trials. In a systematic review of HRQOL following PCI in 700 octogenarians from a total of 11 different studies, the conclusion was that octogenarians improved at least as much as younger patients, and possibly more so in the areas of physical function and improved angina status [30] . In several of these studies, baseline characteristics are reported, although the medical treatments are less well documented. In another systematic review, the authors reached a similar conclusion; HRQOL appears to improve from baseline in the invasive group, but recovery in physical health may be slower than in younger patients [31] . Once again, the results are based on non-randomised studies and registries, with some relatively small studies, and the added risk of selection bias.
In the RITA-3 trial, 1810 patients with NSTEMI and UAP were randomised to either an invasive or conservative strategy [2] . A sub-study of QOL demonstrated that the adoption of an early invasive strategy provided greater gains in HRQOL compared to conservative management [32] . However, that patient cohort had a mean age of 63 years, and only 46 patients were 80 years or older. Considering that physical health scales are strongly influenced by age, any comparison with the After Eighty study is problematic [33] . Another HRQOL sub-study from a randomised controlled trial is the FRISC II [34] . With 2457 individuals included, patients receiving early invasive intervention after an unstable coronary episode experienced a substantial improvement in HRQOL until the 1-year follow-up, compared with patients receiving non-invasive treatment. Again, the FRISC II study population was considerably younger than the After Eighty study, with an average age of 65.
As a conclusion, in patients aged 80 or over with NSTEMI or UAP randomised to an invasive or conservative strategy, no convincing clinical changes in HRQOL, as measured by the SF-36 were seen between the two strategies.
Key points
• After Eighty study randomised patients with non-STelevation myocardial infarction (NSTEMI) or unstable angina pectoris UAP over 80 years to an invasive or conservative strategy.
• The invasive strategy reduced the primary composite endpoint (death, stroke, infarction, revascularisation).
• These results do not, however, translate into changes in health related quality of life (HRQOL), as measured by the SF-36.
Supplementary data
Supplementary data mentioned in the text are available to subscribers in Age and Ageing online.
